Nucleus RadioPharma makes Artbio’s radiopharma assets; Minaris manufactures bluebird’s Lyfgenia
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.
CDMO Nucleus RadioPharma is
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.